Table 1.
Demographic and clinicopathological features of the 41 DLBCL NOS cases included in this study
| Clinicopathological variables | N = 41 | (%) |
|---|---|---|
|
Sex Female Male |
21 20 |
51.2 48.8 |
|
Age (mean age: 61.95 years) < 60 ≥ 60 |
16 25 |
39 61 |
|
Site Oral cavity Oropharynx |
31 10 |
75.6 24.4 |
|
Symptoms Pain Asymptomatic NS |
12 8 21 |
29.3 19.5 51.2 |
|
Swelling Presence Absence NS |
30 9 2 |
73.2 22 4.9 |
|
Ulcer Presence Absence NS |
19 14 8 |
46.3 34.1 19.5 |
|
Bleeding Presence Absence NS |
3 5 33 |
7.3 12.2 80.5 |
|
Bone destruction Presence Absence NS |
6 7 28 |
14.6 17.1 68.3 |
|
Treatment CHOP R-CHOP Others* NS |
6 4 10 21 |
14.6 9.8 24.4 51.2 |
|
Status Alive Dead NS |
10 14 17 |
24.4 34.1 41.5 |
NS: information not specified; CHOP: cyclophosphamide, doxorubicin, vincristine, and prednisone; R-CHOP: rituximab + CHOP
*Others indicates cases for which the chemotherapy scheme was not specified